An open-label randomized controlled trial of low molecular weight heparin for the prevention of central venous line-related thrombotic complications in children: the PROTEKT trial. (Q49174089)
Jump to navigation
Jump to search
scientific article published in January 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | An open-label randomized controlled trial of low molecular weight heparin for the prevention of central venous line-related thrombotic complications in children: the PROTEKT trial. |
scientific article published in January 2003 |
Statements
An open-label randomized controlled trial of low molecular weight heparin for the prevention of central venous line-related thrombotic complications in children: the PROTEKT trial (English)
Patricia Massicotte
Jim A Julian
Michael Gent
Karen Shields
Velma Marzinotto
Barbara Szechtman
Maureen Andrew
PROTEKT Study Group
1 January 2003